Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Chong Kun Dang Pharmaceutical Corp

+ Add to Watchlist

185750:KS

86,300 KRW 4,000 4.43%

As of 02:27:48 ET on 05/22/2015.

Snapshot for Chong Kun Dang Pharmaceutical Corp (185750)

Open: 91,200 Day's Range: 84,600 - 92,200 Volume: 269,366
Previous Close: 90,300 52wk Range: 54,200 - 94,700 1-Yr Rtn: +23.39%

Stock Chart for 185750

No chart data available.
  • 185750:KS 86,300
  • 1D
  • 1M
  • 1Y
90,300
Interactive 185750 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 185750

Current P/E Ratio (ttm) 23.0872
Estimated P/E(12/2015) -
Relative P/E vs. KOSPI 1.2159
Earnings Per Share (KRW) (ttm) 3,738.0000
Est. EPS (KRW) (12/2015) -
Est. PEG Ratio -
Market Cap (M KRW) 812,001.02
Shares Outstanding (M) 9.41
30 Day Average Volume 212,404
Price/Book (mrq) 2.4485
Price/Sale (ttm) 1.4914
Dividend Indicated Gross Yield 0.93%
Cash Dividend (KRW) 800.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 185750

No data available

Company Profile & Key Executives for 185750

Chong Kun Dang Pharmaceutical Corp. manufactures pharmaceutical products. The Company produces medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.

Rhee Jang-HanChairmanKim Jung-WooVice Chairman/Co-Rep Director
Kim Kyu-DonCo-Rep Director/VPKim Seong-GiSenior Managing Director
More Company Profile & Key Executives for 185750

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil